Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease

Abstract Maple Syrup Urine Disease (MSUD, OMIM# 248600) is an autosomal recessive inborn error of metabolism characterized by elevated branched chain amino acids (BCAA) leucine/isoleucine and valine in blood of affected children. The phenotypic and genotypic spectrum of MSUD is largely unreported in...

Full description

Saved in:
Bibliographic Details
Main Authors: Zeinab S. Abdelkhalek, Shadia M. Hussein, Iman G. Mahmoud, Areef Ramadan, Mona A. Kamel, Marian Y. Girgis, Mohamed A. Elmonem
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-78105-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846158607309078528
author Zeinab S. Abdelkhalek
Shadia M. Hussein
Iman G. Mahmoud
Areef Ramadan
Mona A. Kamel
Marian Y. Girgis
Mohamed A. Elmonem
author_facet Zeinab S. Abdelkhalek
Shadia M. Hussein
Iman G. Mahmoud
Areef Ramadan
Mona A. Kamel
Marian Y. Girgis
Mohamed A. Elmonem
author_sort Zeinab S. Abdelkhalek
collection DOAJ
description Abstract Maple Syrup Urine Disease (MSUD, OMIM# 248600) is an autosomal recessive inborn error of metabolism characterized by elevated branched chain amino acids (BCAA) leucine/isoleucine and valine in blood of affected children. The phenotypic and genotypic spectrum of MSUD is largely unreported in Egypt. We recruited ten patients (4 males/6 females, 2weeks-12years) from nine unrelated families with clinical and biochemical evidence of MSUD. We performed Sanger sequencing for the three most-commonly responsible genes: BCKDHA, BCKDHB and DBT and conducted exome sequencing for unresolved cases. Through Sanger sequencing, we detected eight homozygous pathogenic/likely pathogenic variants (four in BCKDHB, three in BCKDHA and one in DBT gene) in eight different families. The proband of family VI, who had no significant genetic findings by Sanger, had a peculiar phenotype and atypical radiological findings. His exome sequencing revealed a previously reported homozygous likely pathogenic variant in the RARS2 gene (NM_020320.5:c.1026G > A;p.(Met342Ile)) causing the mitochondrial-encephalopathy disorder pontocerebellar hypoplasia, type 6 (OMIM# 611523). Furthermore, the copy-number-variant analysis of the exome data revealed a biallelic duplication affecting exons 2–6 of the BCKDHB gene (GRCh38: Chr.6-g.80127496:80171441dup) evaluated as variant of uncertain significance but expected to cause a breakpoint and may disrupt gene function, which can explain the markedly elevated BCAA levels in the patient’s blood. In conclusion, we expanded the genotypic and phenotypic spectrum of the disease and showed that aggressive intervention with specific treatment in the first few days of life resulted in normal development even in a developing country setting. Inclusion of MSUD in the national newborn screening program in Egypt is highly recommended.
format Article
id doaj-art-8e0482058803486e94a6985389a539b4
institution Kabale University
issn 2045-2322
language English
publishDate 2024-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-8e0482058803486e94a6985389a539b42024-11-24T12:21:50ZengNature PortfolioScientific Reports2045-23222024-11-0114111210.1038/s41598-024-78105-yExpanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine diseaseZeinab S. Abdelkhalek0Shadia M. Hussein1Iman G. Mahmoud2Areef Ramadan3Mona A. Kamel4Marian Y. Girgis5Mohamed A. Elmonem6Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo UniversityCentral laboratories, Cairo University Hospitals, Cairo UniversityPediatric Neurology Department, Metabolic Division, Faculty of Medicine, Cairo University Children’s HospitalPediatric Neurology Department, Metabolic Division, Faculty of Medicine, Cairo University Children’s HospitalPediatric Neurology Department, Metabolic Division, Faculty of Medicine, Cairo University Children’s HospitalPediatric Neurology Department, Metabolic Division, Faculty of Medicine, Cairo University Children’s HospitalClinical and Chemical Pathology Department, Faculty of Medicine, Cairo UniversityAbstract Maple Syrup Urine Disease (MSUD, OMIM# 248600) is an autosomal recessive inborn error of metabolism characterized by elevated branched chain amino acids (BCAA) leucine/isoleucine and valine in blood of affected children. The phenotypic and genotypic spectrum of MSUD is largely unreported in Egypt. We recruited ten patients (4 males/6 females, 2weeks-12years) from nine unrelated families with clinical and biochemical evidence of MSUD. We performed Sanger sequencing for the three most-commonly responsible genes: BCKDHA, BCKDHB and DBT and conducted exome sequencing for unresolved cases. Through Sanger sequencing, we detected eight homozygous pathogenic/likely pathogenic variants (four in BCKDHB, three in BCKDHA and one in DBT gene) in eight different families. The proband of family VI, who had no significant genetic findings by Sanger, had a peculiar phenotype and atypical radiological findings. His exome sequencing revealed a previously reported homozygous likely pathogenic variant in the RARS2 gene (NM_020320.5:c.1026G > A;p.(Met342Ile)) causing the mitochondrial-encephalopathy disorder pontocerebellar hypoplasia, type 6 (OMIM# 611523). Furthermore, the copy-number-variant analysis of the exome data revealed a biallelic duplication affecting exons 2–6 of the BCKDHB gene (GRCh38: Chr.6-g.80127496:80171441dup) evaluated as variant of uncertain significance but expected to cause a breakpoint and may disrupt gene function, which can explain the markedly elevated BCAA levels in the patient’s blood. In conclusion, we expanded the genotypic and phenotypic spectrum of the disease and showed that aggressive intervention with specific treatment in the first few days of life resulted in normal development even in a developing country setting. Inclusion of MSUD in the national newborn screening program in Egypt is highly recommended.https://doi.org/10.1038/s41598-024-78105-yMaple-syrup-urine disease; Sanger sequencingExome sequencingNovel variantEgypt
spellingShingle Zeinab S. Abdelkhalek
Shadia M. Hussein
Iman G. Mahmoud
Areef Ramadan
Mona A. Kamel
Marian Y. Girgis
Mohamed A. Elmonem
Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease
Scientific Reports
Maple-syrup-urine disease; Sanger sequencing
Exome sequencing
Novel variant
Egypt
title Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease
title_full Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease
title_fullStr Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease
title_full_unstemmed Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease
title_short Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease
title_sort expanding the genotypic and phenotypic spectrum of egyptian children with maple syrup urine disease
topic Maple-syrup-urine disease; Sanger sequencing
Exome sequencing
Novel variant
Egypt
url https://doi.org/10.1038/s41598-024-78105-y
work_keys_str_mv AT zeinabsabdelkhalek expandingthegenotypicandphenotypicspectrumofegyptianchildrenwithmaplesyrupurinedisease
AT shadiamhussein expandingthegenotypicandphenotypicspectrumofegyptianchildrenwithmaplesyrupurinedisease
AT imangmahmoud expandingthegenotypicandphenotypicspectrumofegyptianchildrenwithmaplesyrupurinedisease
AT areeframadan expandingthegenotypicandphenotypicspectrumofegyptianchildrenwithmaplesyrupurinedisease
AT monaakamel expandingthegenotypicandphenotypicspectrumofegyptianchildrenwithmaplesyrupurinedisease
AT marianygirgis expandingthegenotypicandphenotypicspectrumofegyptianchildrenwithmaplesyrupurinedisease
AT mohamedaelmonem expandingthegenotypicandphenotypicspectrumofegyptianchildrenwithmaplesyrupurinedisease